Frantz Viral Therapeutics
PrivateLast Round
Joint Venture
Jun 1, 2015
Company Overview
Frantz Viral Therapeutics is a biotechnology company that develops non-surgical, topical treatments for HPV-induced conditions and cancers using artemisinin-related compounds.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Frantz Viral Therapeutics Comparables
Compare Frantz Viral Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amplexd Therapeutics | 88% | |
| Antiva Biosciences | 84% | |
| Asieris Pharmaceuticals | 72% | |
Frantz Viral Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Joint Venture | Jun 1, 2015 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2015
Secured funding from Frantz Medical Group and Georgetown University.
Frantz Viral Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Frantz Viral Therapeutics's valuation, stock price, and market status.